Brief: Nanoform Completes First Dosing Of Nanoformed Drug

Nanoform Finland Oyj

21/12/2020 07:05

Dec 21 (Reuters) - Nanoform Finland Plc  NANOFH.HE :
    * FIRST DOSING OF NANOFORMED DRUG SUCCESSFULLY ACCOMPLISHED
    * RESULTS ARE EXPECTED BEFORE END OF Q2/2021.
    * NANOFORM HAS NOW ACHIEVED ALL ITS NEAR-TERM BUSINESS
TARGETS FOR
2020 AND 2021 ANNOUNCED IN RELATION TO IPO
    * NEW NEAR-TERM BUSINESS TARGETS, IN ADDITION TO PREVIOUSLY
(NOVEMBER 27TH) ANNOUNCED "FIRST BIOLOGICS POC PROJECT IN 2021",
WILL BE COMMUNICATED IN COMING MONTHS

Source text for Eikon:  ID:nWkrbf88YC 
Further company coverage:  NANOFH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))